Full 2 Month Supply for $69: Only $1.15 per day!


AutoShipped to you every 2 months so you never forget! Only 98 Cents per day!


For men who need a little help with,
well, you know...
(and women can use it too!)

Physician proprietary formula created by Steven Dominguez, MD, MPH. 

Need to know more about why
PoSiFo Rx is the most effective formula available?
Read on:

*Clinically proven results in Dr. Dominguez's male patients resulting in significantly enhanced sexual desire, size, hardness, ejaculate volume, and prolonged performance pleasure.

*Yohimbe – Free. No Yohimbe side effect worries.

*For Ultimate results use with the ThermDissolve ® System and NeuroMilagrosTM Energy supplements.Sign up for Autoship and get a free Posifo T-shirt to announce your commitment to your stamina. Limited time offer.

PoSiFo Rx is a dietary supplement designed for men desiring to enhance their DAILY libido and sexual performance without spending $18-$20 each pill or $540 -$600 per month. Your 60 day POSIFO Rx cost: $69.00 ($1.15 per day)!!! 

 Individual results may vary depending on multiple factors including your health, diet and exercise.

I’m Looking Amazing, Feeling Great, and it’s Just For Me!®


A message about Posifo RX from Dr. Steven Dominguez:



You've seen the ads, you've seen the Google search webpage, you've seen the endorsements (physician - though really a psychologist, naturalist, sex therapist,...).  Yeah, I've seen them too. Did you notice how they are sold by the same company with the same gimicky sales pitch?   


Give a me minute of your time to give you some straight talk. Straight talk from me, a physician (I've been an M.D. since 1988 and I trained in Surgery at the Cleveland Clinic and in Medicine at UCLA) who has cared for thousands of men with needs unmet by the hype of flashy ads and the "buy now and get 2 free" b.s.  Look, I designed the PoSiFo Rx formula to work for me and my patients (my patients include other M.D.'s, lawyers, Fire, Police, RN's, Chiropractors, construction, executives, school teachers, truck drivers, plumbers, and athletes).  Look at the ingredient panel and decide for yourself if PoSiFo Rx has ALL the right ingredients in strengths that are known to work.  You won't see any tricks like putting in a flash amount just claim its there.  If I listed it, it's in PoSiFo Rx in a percentage that works!!  Let me give you some academic knowledge.  You can use this information to make your decision on buying PoSiFo Rx or whichever other product is right for you.  It's a tough decision, especially if you are like most of us over 40 and starting to worry about our health and function.  So read on and if you have any questions, contact me



"There exist fundamental rights for the individual, including the right to sexual health and a capacity to enjoy and control sexual and reproductive behavior in accordance with a social personal ethic -- freedom from fear, shame, guilt, false beliefs and other factors inhibiting sexual response and impairing sexual relationships -- freedom from organic disorders, disease and deficiencies that interfere with sexual and reproductive function."

-World Health Organization Guidelines


So you feel you are the ONLY one with, well you know... Sorry, you’re not that special. Here are the facts:

Studies focusing on the United States indicate that up to 30 million American men - including up to 52% of those aged 40 to 70 years - have sexual health issues. This accounts for more than 500,000 doctor visits each year.


Still think you’re special?

Worldwide, more than 150 million men experience sexual health problems. Given the advancing median age in Western industrial countries, together with population growth in developing nations, this figure is projected to increase to more than 320 million by the year 2025.


Oh yeah right, OK. So, you’re 40 something.....

As with other chronic disorders, the prevalence of sexual health issues increases with age. The Massachusetts Male Aging Study estimated that approximately 40% of men aged 40 years and 67% of those aged 70 years had sexual health issues. According to this study, about 1 in 7 men aged 70 years suffered from the complete inability to attain and/or maintain an erection, compared with 1 in 20 men at age 40.


Now what’s your excuse? Oh, sex is all about you, right?

Adults of all ages view sexual activity as a key issue in quality of life (QOL). In the United States, 91% of married adult men and 84% of married adult women ranked a satisfying sex life as important. It is therefore not surprising that sex issues are significantly associated with reduced QOL and emotional stress that can damage relationships between partners.


Here’s the bottom line:

Sexual health issues can compromise self-image and self-esteem, and many men associate the core values of manhood with sexual function. Low levels of life satisfaction, as well as reduced levels of physical and emotional satisfaction and overall well-being, are associated with sexual health issues.

According to a US National Institutes of Health Consensus Development Panel on Impotence, "In men of all ages, erectile failure may diminish willingness to initiate sexual relationships because of fear of inadequate sexual performance or rejection. Because men, especially older men, are particularly sensitive to the social support of intimate relationships, withdrawal from these relationships because of such fears may have a negative effect on their overall health."



Here’s what academic research says PoSiFo’s ingredients may do for you.

PoSiFo Rx is not a drug. PoSiFo Rx is a dietary supplement. PoSiFo Rx is my research based herbal formulation designed to help men like you and me.

•1. Increase L-DOPA and its metabolites, which include dopamine, epinephrine and norepinephrine levels in the brain

•2. These increased levels may be correlated with an increase of sexual behavior

•3. These increased levels may also increase plasma testosterone level

•4. L-DOPA and its metabolite dopamine stimulate the hypothalamus and forebrain to secrete gonadotropin-releasing hormone (GnRH)

•5. GnRH causes the anterior pituitary gland to secrete follicle stimulating hormone (FSH) and luteinizing hormone (LH) causing increased synthesis of testosterone by Leydig cells of the testis

•6. Spermtogenesis is controlled by the hypothalamus and anterior pituitary working together to produce and transport increased volumes of sperm and ejaculate fluid

•7. Increased dopamine level in the brain may not only optimize the release of hormones, including testosterone, leading to increased sexual drive and improved performance, but it may also accomplish reduction of psychological stress

•8. Therefore, taking PoSiFo Rx may contribute to proper functioning of male genital system and facilitate sperm production and transport, filling and contraction of seminal vesicles and increased blood flow to the corpus caverneosum


Do you want more research? Here you go! Have fun!

  1. Brisson TE, Broderick GA. Can patients failing a PDE 5-inhibitor be rescued by another tablet? An objective assessment of 327 patients with erectile dysfunction. Program and abstracts of the Sexual Medicine Society of North America Fall Meeting; November 17-20, 2005; New York, NY. Abstract 14
  2. Kupelian V, Shabsigh R, Travison TG, Araujo AB, O'Donnell AB, McKinlay JB. Is there a relationship between erectile dysfunction and sex-hormones? Results from the Massachusetts Male Aging Study (MMAS). Program and abstracts of the Sexual Medicine Society of North America Fall Meeting; November 17-20, 2005; New York, NY. Abstract 80
  3. Laumann E, Glasser D, West S, Kang J-H, Rosen R, Carson C. Correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: results from the Male Attitudes Regarding Sexual Health (MARSH) survey. Program and abstracts of the Sexual Medicine Society of North America Fall Meeting; November 17-20, 2005; New York, NY. Abstract 84
  4. Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Cosponsored by the World Health Organization, International Consultation on Urological Diseases, and Société Internationale d'Urologie. Paris, France: July 1-3, 1999. Geneva, Switzerland: World Health Organization; 1999:709-726.
  5. Ralph D, McNicholas T, for the Erectile Dysfunction Alliance. UK management guidelines for erectile dysfunction. BMJ. 2000;321:499-503.
  6. NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. JAMA. 1993;270:83-90.
  7. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.
  8. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000;12(suppl 4):S6-S11.
  9. Aytaç IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50-56.
  10. Jønler M, Moon T, Brannan W, Stone NN, Heisey D, Bruskewitz RC. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol. 1995;75:651-655.
  11. Martin-Morales A, Sanchez-Cruz JJ, Sáenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166:569-575.
  12. Meuleman EJ, Donkers LH, Robertson C, Keech M, Boyle P, Kiemeney LA. Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study. Ned Tijdschr Geneeskd. 2001;145:576-581.
  13. Marumo K, Nagatsuma K, Murai M. Effect of aging and diseases on male sexual function assessed by the International Index of Erectile Function. Nippon Hinyokika Gakkai Zasshi. 1999;90:911-919.
  14. Seyoum B. Impotence in Ethiopian diabetic men. East Afr Med J. 1998;75:208-210.
  15. Solstad K, Hertoft P. Frequency of sexual problems and sexual dysfunction in middle-aged Danish men. Arch Sex Behav. 1993;22:51-58.
  16. Marwick C. Survey says patients expect little physician help on sex. JAMA. 1999;281:2173-2174.
  17. Intili H. Impotence and perceived partner support. Urol Nurs. 1998;18:279-280, 287.
  18. Rust J, Golombok S, Collier J. Marital problems and sexual dysfunction: how are they related? Br J Psychiatry. 1988;152:629-631.
  19. Fugl-Meyer AR, Lodnert G, Branholm I-B, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res. 1997;9:141-148.
  20. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537-544.
  21. Gheorghiu S, Godschalk M, Gentili A, Mulligan T. Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction. J Urol. 1996;156:80-81.
  22. Chun J, Carson CC III. Physician-patient dialogue and clinical evaluation of erectile dysfunction. Urol Clin North Am. 2001;28:249-258.
  23. Chew KK, Earle CM, Stuckey BGA, Jamrozik K, Keogh EJ. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res. 2000;12:41-45.
  24. Struening EL, Perlick DA, Link BG, Hellman F, Herman D, Sirey JA. Stigma as a barrier to recovery: the extent to which caregivers believe most people devalue consumers and their families. Psychiatr Serv. 2001;52:1633-1638.
  25. Perlick DA. Special section on stigma as a barrier to recovery: introduction. Psychiatr Serv. 2001;52:1613-1614.
  26. Sharlip ID, Jarow JP, Belker AM, Lipshultz LI, Sigman M, Thomas AJ, et al. Best practice policies for male infertility. Fertil Steril ( 2002;) 77:: 873–82.
  27. McGrady AV. Effects of psychological stress on male reproduction: a review. Arch Androl ( 1984;) 13:: 1–7.
  28. Gill GE, Ollero M, Lopez MC. Differential production of reactive oxygen species by subsets of human spermatozoa at different stages of maturation. Hum Reprod ( 2001;) 16:: 1922–30.
  29. Wang L, Muxin G, Nishida H, Shirakawa C, Sato S, Konishi T. Psychological stress-induced oxidative stress as a model of sub-healthy condition and the effect of TCM. Evid Based Complement Alternat Med ( 2006;) 4:: 195–202.
  30. Eskiocak S, Gozen AS, Kilic AS, Molla S. Association between mental stress and some antioxidant enzymes of seminal plasma. Indian J Med Res ( 2005;) 122:: 491–6.
  31. Mahdi AA, Bano F, Singh R, Singh RK, Siddiqui MS, Hasan M. Seminal plasma superoxide dismutase and catalase activities in infertile men. Med Sci Res ( 1999;) 27:: 201–3.
  32. Sikka SC. Relative impact of oxidative stress on male reproductive function. Curr Med Chem ( 2001;) 8:: 851–62.
  33. Dahanukar SA, Hazra A. Ayurveda unravelled. In: Heal with Herbs —Dahanukar SA, ed. ( 1995;) New Delhi, India: Publications and Information Directorate, Council of Scientific and Industrial Research;. 53–74.
  34. Kaphle K, Wu LS, Yang NYJ, Lin JH. Herbal medicine research in Taiwan. Evid Based Complement Alternat Med ( 2006;) 3:: 149–55.
  35. Yang NYJ, Kaphle K, Wang PH, Jong DS, Wu LS, Lin JH. Effect of aqueous extracts of betel quid and its constituents on testosterone production by dispersed mouse interstitial cells. Am J Chin Med ( 2004;) 32:: 705–15.
  36. Molloy SA, Rowan EN, O’Brien JT, McKeith IG, Wesnes K, Burn DJ. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatr ( 2006;) 77:: 1323–8.
  37. Sharma ML, Chandhoke N, Ray Ghatak BJ, Jamwal KS, Gupta OP, Singh GB. Pharmacological screening of Indian medicinal plants. Indian J Exp Biol ( 1978;) 16:: 228–35.
  38. World Health Organization. Laboratory manual for the examination of human semen and sperm cervical mucus interaction ( 1999;) 4th. New York: Cambridge University Press.
  39. Spielberger CD, Gorsuch RL, Lushene RE. STAI manual for the State-Trait Anxiety Inventory ( 1970;) Palo Alto, CA, USA: Consulting Psychologist Press.
  40. Konch Singh D. Unani Dravvyagunadarsh, Vol. 2. Singh D, ed. ( 1974;) Varanasi, India: Jivan Shiksha Mudralay Limited, Lucknow, Uttar Pradesh, India. 101–2. (Kiwach).
  41. McCord JM, Fridovich I. Superoxide dismutase: an enzyme function for erythrocuprin. J Biol Chem ( 1969;) 244:: 6049–55.
  42. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem ( 1976;) 74:: 214–26.
  43. Foster LB, Dunn RT. Single antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma. Clin Chem ( 1974;) 20:: 365–8.
  44. Nagro-Vilar A. Stress and other environmental factors affecting fertility in men and women; overview. Env Health Prospect Suppl ( 1993;) 101 (Suppl 2):: 59–64.
  45. Hardy MP, Gao HB, Dong Q, Ge R, Wang Q, Chai WR, et al. Stress hormone and male reproductive function. Cell Tissue Res ( 2005;) 322:: 147–53.
  46. Axelrod J, Reisine TD. Stress hormones: their interaction and regulation. Science ( 1984;) 224:: 452–6.
  47. Sato Y, Suzuki N, Horita H, Wada H, Shibuya A, Adachi H, et al. Effect of long term psychological stress on sexual behavior and brain catecholamine levels. J Androl ( 1996;) 17:: 83–90.
  48. Vermes I, Toth EK, Telegdy G. Effects of drugs on brain neurotransmitter and pituitary testicular function in male rats. Horm Res ( 1979;) 10:: 222–32.
  49. Mendis-Handagama SMLC, Siril Ariyaratne HB. Leydig cells, thyroid hormones and steriodogenesis. Indian J Exp Biol ( 2005;) 43:: 939–62.
  50. Kaphale K, Wu LS, Tsai YF. Effects of putative neurotransmitters on testosterone production from in vitro mice interstitial cells culture. J Anim Vet Adava ( 2003;) 2:: 119–25.
  51. Fait G, Vered Y, Yogev L, Gamzu R, Lessing JB, Paz G, et al. High levels of catecholamines in human semen: a preliminary study. Andrologia ( 2001;) 33:: 347–50.